EquityBulls

Keywords Selected: USFDA

Stock Report

Alembic Pharmaceuticals Limited's Partner NATCO Pharma Limited receives USFDA Tentative Approval for Olaparib Tablets, 100 mg and 150 mg
NATCO receives Tentative Approval for Olaparib Tablets from the U.S. FDA
USFDA inspection at InvaGen manufacturing facility in Central Islip, Long Island, NY, USA
Completion of US-FDA Inspection at Sterile Product Division facility at Bengaluru
Ajanta Pharma Ltd receives EIR from USFDA for Paithan facility
Lupin Receives EIR from U.S. FDA for its Somerset Facility with VAI Classification
US FDA inspection at Glenmark Pharmaceuticals Ltd's manufacturing facility in Goa, India
Completion of US FDA Inspection at Auroactive Pharma Pvt Ltd
Alembic Pharmaceuticals Limited receives USFDA Final Approval for Dapsone Gel, 5%
Lupin receives Tentative Approval from U.S. FDA for Enzalutamide Tablets
Completion of US FDA Pre-Approval Inspection at Eugia Steriles Private Limited
Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Binimetinib Tablets, 45 mg
Classification of US FDA Inspection at Unit-III of Eugia Pharma Specialities Ltd, Pashamylaram as OAI
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Tretinoin Cream USP, 0.05%
USFDA inspection at Cipla Ltd's manufacturing facility in Verna, Goa, India
Alembic Pharmaceuticals Ltd announces USFDA Tentative Approval for Larotrectinib Capsules, 25 mg and 100 mg
Concord Biotech Ltd receives ANDA approval for Tofacitinib Tablets, 5 mg and 10 mg
Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Haloperidol Tablets, USP, 1 mg, 2 mg, 5 mg, 10 mg, and 20 mg
Lupin receives approval from U.S. FDA for Ranluspec™ (ranibizumab) Injection
Aurobindo Pharma receives final US FDA approval for Tofacitinib Tablets, 5 mg and 10 mg
Granules Pharmaceuticals, Inc. Receives USFDA EIR for Chantilly Facility
NATCO and Lupin receive approval from U.S. FDA for Eribulin Mesylate Injection
Concord Biotech Ltd receives ANDA approval from USFDA for Mycophenolate Mofetil for Oral Suspension USP
Lupin's Ankleshwar Facility Receives EIR from U.S. FDA